The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management (Fourth Edition) [Kindle Edition] Author: Martin A. Voet | Language: English | ISBN:
B00I13N5VO | Format: PDF, EPUB
The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management
You can download The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management for everyone book with Mediafire Link Download Link This Fourth Edition of The Generic Challenge provides important new updates on current regulatory, legal and commercial issues affecting brand and generic pharmaceutical products, including new laws establishing generics for biologics, and changes brought about by the recently enacted America Invents Act. It explains clearly and understandably the roles of patents, FDA regulation of drugs and the Hatch Waxman Act in commercial drug development in light of generic challenges and how improvements in innovative drug products provide benefits to patients while extending the commercial lives of the drugs. There is simply no other book of its kind available on this important subject. Direct download links available for The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management (Fourth Edition) [Kindle Edition]
- File Size: 3879 KB
- Print Length: 194 pages
- Publisher: BrownWalker Press; 4 edition (January 23, 2014)
- Sold by: Amazon Digital Services, Inc.
- Language: English
- ASIN: B00I13N5VO
- Text-to-Speech: Enabled
X-Ray:
- Lending: Not Enabled
Excellent book. Great shipping. I don't even read the book.
By LHuynh
Readers interested in this 2014 Fourth Edition may want to look at the many positive reviews on Amazon for the 2011Third Edition of this book. This Fourth Edition expands the third edition with updates on key changes in FDA law and regulations, including FDA "safe harbor", the new 5 year add-on exclusivity for QIDPs, important new court decisions since 2011, including new Supreme Court decisions on "reverse payments" in settlements of Hatch Waxman litigation, patent use codes and patentability of naturally occurring compounds including human genes and adds a new chapter on Generics for Biologic Drugs (biosimilars).
By Martin A. Voet
The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management Download
Please Wait...